What insurance policy changes affect code N90.89?

There are 3 tracked policy changes affecting code N90.89, including updates from Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code N90.89?

Payers that have issued tracked updates for code N90.89 include: Blue Cross & Blue Shield of Mississippi.

How do I get notified when code N90.89 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code N90.89. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code N90.89?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

N90.89 Insurance Policy Changes

ICD-10 N90.89 is officially defined as "Other specified noninflammatory disorders of vulva and perineum." code N90.89 is referenced in 3 tracked payer policy changes from Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code N90.89 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Targeted Phototherapy and Psoralen with Ultraviolet A for Vitiligo
Targeted phototherapy is considered investigational for the treatment of vitiligo. PUVA (psoralen plus ultraviolet A) for vitiligo that is not responsive to other forms of conservative therapy, such as topical corticosteroids, coal/tar preparations, and ultraviolet light, may be considered medically necessary. PUVA is generally not recommended for home therapy, and the individual needs to be assessed on a regular basis for effectiveness of the therapy and development of side effects.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Free Testosterone Testing
Serum free testosterone (CPT 84402) is medically necessary to distinguish a sex hormone-binding globulin (SHBG) abnormality from hypogonadism in obese males with symptoms of hypogonadism when total testosterone is low, to diagnose hyperandrogenism in symptomatic females, and in patients with a medical diagnosis that may increase or decrease SHBG levels. It is not medically necessary to diagnose testosterone deficiency in non-obese males with symptoms of hypogonadism, or when performed for screening of asymptomatic patients. Free testosterone should be performed by equilibrium dialysis, and free testosterone measured by an analog method should never be ordered.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Estrogen Hormone Testing: Estradiol and Estrone
Measurement of estrogen hormones is considered medically necessary to evaluate ovarian function in females with symptoms of hypoestrogenism or hyperestrogenism, to diagnose hyperestrogenism in symptomatic males, to monitor hormone replacement therapy in postmenopausal females, and to monitor antiestrogen therapy. Measurement of estrogen hormones is considered not medically necessary when performed for screening purposes in asymptomatic patients. The covered tests are total estradiol (CPT 82670), fractionated estrogens (CPT 82671), total estrogens (CPT 82672), estrone (CPT 82679), and free estradiol by direct measurement, such as equilibrium dialysis (CPT 82681).

Watch N90.89

Get one email when a payer policy names N90.89, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Targeted Phototherapy and Psoralen with Ultraviolet A for Vitiligo

Free Testosterone Testing

Estrogen Hormone Testing: Estradiol and Estrone

What insurance policy changes affect code N90.89?

Which payers have updated policy for code N90.89?

How do I get notified when code N90.89 policy changes?

Why do payers change policies for code N90.89?